List of Tables
Table 1. Global Sickle Cell Disease Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sickle Cell Disease Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sickle Cell Disease Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sickle Cell Disease Drug Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Sickle Cell Disease Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sickle Cell Disease Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sickle Cell Disease Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sickle Cell Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sickle Cell Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sickle Cell Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of Sickle Cell Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Disease Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sickle Cell Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sickle Cell Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Sickle Cell Disease Drug Sales Market Share by Region (2020-2025)
Table 19. Global Sickle Cell Disease Drug Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Sickle Cell Disease Drug Sales Market Share by Region (2026-2031)
Table 21. Global Sickle Cell Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sickle Cell Disease Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Sickle Cell Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sickle Cell Disease Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Sickle Cell Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sickle Cell Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Sickle Cell Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Sickle Cell Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sickle Cell Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sickle Cell Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sickle Cell Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Sickle Cell Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Sickle Cell Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sickle Cell Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sickle Cell Disease Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sickle Cell Disease Drug Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Sickle Cell Disease Drug Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Sickle Cell Disease Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sickle Cell Disease Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sickle Cell Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sickle Cell Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Sickle Cell Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Sickle Cell Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sickle Cell Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sickle Cell Disease Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Sickle Cell Disease Drug Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sickle Cell Disease Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sickle Cell Disease Drug Sales (K Pcs) by Type (2020-2025)
Table 51. Global Sickle Cell Disease Drug Sales (K Pcs) by Type (2026-2031)
Table 52. Global Sickle Cell Disease Drug Sales Market Share by Type (2020-2025)
Table 53. Global Sickle Cell Disease Drug Sales Market Share by Type (2026-2031)
Table 54. Global Sickle Cell Disease Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sickle Cell Disease Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sickle Cell Disease Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Sickle Cell Disease Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Sickle Cell Disease Drug Sales (K Pcs) by Application (2020-2025)
Table 61. Global Sickle Cell Disease Drug Sales (K Pcs) by Application (2026-2031)
Table 62. Global Sickle Cell Disease Drug Sales Market Share by Application (2020-2025)
Table 63. Global Sickle Cell Disease Drug Sales Market Share by Application (2026-2031)
Table 64. Global Sickle Cell Disease Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sickle Cell Disease Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sickle Cell Disease Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Sickle Cell Disease Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Sickle Cell Disease Drug Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Sickle Cell Disease Drug Price (USD/Pcs) by Application (2026-2031)
Table 70. Acceleron Pharma Inc Company Information
Table 71. Acceleron Pharma Inc Description and Business Overview
Table 72. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Acceleron Pharma Inc Sickle Cell Disease Drug Product
Table 74. Acceleron Pharma Inc Recent Developments/Updates
Table 75. Addmedica SAS Company Information
Table 76. Addmedica SAS Description and Business Overview
Table 77. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Addmedica SAS Sickle Cell Disease Drug Product
Table 79. Addmedica SAS Recent Developments/Updates
Table 80. Angiocrine Bioscience Inc Company Information
Table 81. Angiocrine Bioscience Inc Description and Business Overview
Table 82. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product
Table 84. Angiocrine Bioscience Inc Recent Developments/Updates
Table 85. Annexin Pharmaceuticals AB Company Information
Table 86. Annexin Pharmaceuticals AB Description and Business Overview
Table 87. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product
Table 89. Annexin Pharmaceuticals AB Recent Developments/Updates
Table 90. ArQule Inc Company Information
Table 91. ArQule Inc Description and Business Overview
Table 92. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. ArQule Inc Sickle Cell Disease Drug Product
Table 94. ArQule Inc Recent Developments/Updates
Table 95. Bio Products Laboratory Ltd Company Information
Table 96. Bio Products Laboratory Ltd Description and Business Overview
Table 97. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product
Table 99. Bio Products Laboratory Ltd Recent Developments/Updates
Table 100. Bioverativ Inc Company Information
Table 101. Bioverativ Inc Description and Business Overview
Table 102. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Bioverativ Inc Sickle Cell Disease Drug Product
Table 104. Bioverativ Inc Recent Developments/Updates
Table 105. bluebird bio Inc Company Information
Table 106. bluebird bio Inc Description and Business Overview
Table 107. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. bluebird bio Inc Sickle Cell Disease Drug Product
Table 109. bluebird bio Inc Recent Developments/Updates
Table 110. Bristol-Myers Squibb Co Company Information
Table 111. Bristol-Myers Squibb Co Description and Business Overview
Table 112. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product
Table 114. Bristol-Myers Squibb Co Recent Developments/Updates
Table 115. Calimmune Inc Company Information
Table 116. Calimmune Inc Description and Business Overview
Table 117. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Calimmune Inc Sickle Cell Disease Drug Product
Table 119. Calimmune Inc Recent Developments/Updates
Table 120. CRISPR Therapeutics Company Information
Table 121. CRISPR Therapeutics Description and Business Overview
Table 122. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. CRISPR Therapeutics Sickle Cell Disease Drug Product
Table 124. CRISPR Therapeutics Recent Developments/Updates
Table 125. CSL Ltd Company Information
Table 126. CSL Ltd Description and Business Overview
Table 127. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. CSL Ltd Sickle Cell Disease Drug Product
Table 129. CSL Ltd Recent Developments/Updates
Table 130. Daiichi Sankyo Co Ltd Company Information
Table 131. Daiichi Sankyo Co Ltd Description and Business Overview
Table 132. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product
Table 134. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 135. Editas Medicine Inc Company Information
Table 136. Editas Medicine Inc Description and Business Overview
Table 137. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Editas Medicine Inc Sickle Cell Disease Drug Product
Table 139. Editas Medicine Inc Recent Developments/Updates
Table 140. Errant Gene Therapeutics LLC Company Information
Table 141. Errant Gene Therapeutics LLC Description and Business Overview
Table 142. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product
Table 144. Errant Gene Therapeutics LLC Recent Developments/Updates
Table 145. Gamida Cell Ltd Company Information
Table 146. Gamida Cell Ltd Description and Business Overview
Table 147. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Gamida Cell Ltd Sickle Cell Disease Drug Product
Table 149. Gamida Cell Ltd Recent Developments/Updates
Table 150. Genethon SA Company Information
Table 151. Genethon SA Description and Business Overview
Table 152. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Genethon SA Sickle Cell Disease Drug Product
Table 154. Genethon SA Recent Developments/Updates
Table 155. Gilead Sciences Inc Company Information
Table 156. Gilead Sciences Inc Description and Business Overview
Table 157. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Gilead Sciences Inc Sickle Cell Disease Drug Product
Table 159. Gilead Sciences Inc Recent Developments/Updates
Table 160. Global Blood Therapeutics Inc Company Information
Table 161. Global Blood Therapeutics Inc Description and Business Overview
Table 162. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product
Table 164. Global Blood Therapeutics Inc Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Sickle Cell Disease Drug Distributors List
Table 168. Sickle Cell Disease Drug Customers List
Table 169. Sickle Cell Disease Drug Market Trends
Table 170. Sickle Cell Disease Drug Market Drivers
Table 171. Sickle Cell Disease Drug Market Challenges
Table 172. Sickle Cell Disease Drug Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sickle Cell Disease Drug
Figure 2. Global Sickle Cell Disease Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sickle Cell Disease Drug Market Share by Type: 2024 & 2031
Figure 4. ARQ-092 Product Picture
Figure 5. BIVV-003 Product Picture
Figure 6. CAL-H Product Picture
Figure 7. CTX-001 Product Picture
Figure 8. DRX-194 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Sickle Cell Disease Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Sickle Cell Disease Drug Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Global Sickle Cell Disease Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sickle Cell Disease Drug Market Size (2020-2031) & (US$ Million)
Figure 17. Global Sickle Cell Disease Drug Sales (2020-2031) & (K Pcs)
Figure 18. Global Sickle Cell Disease Drug Average Price (USD/Pcs) & (2020-2031)
Figure 19. Sickle Cell Disease Drug Report Years Considered
Figure 20. Sickle Cell Disease Drug Sales Share by Manufacturers in 2024
Figure 21. Global Sickle Cell Disease Drug Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Sickle Cell Disease Drug Players: Market Share by Revenue in Sickle Cell Disease Drug in 2024
Figure 23. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Sickle Cell Disease Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Sickle Cell Disease Drug Sales Market Share by Country (2020-2031)
Figure 26. North America Sickle Cell Disease Drug Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Sickle Cell Disease Drug Sales Market Share by Country (2020-2031)
Figure 30. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2020-2031)
Figure 31. Germany Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Sickle Cell Disease Drug Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Sickle Cell Disease Drug Revenue Market Share by Region (2020-2031)
Figure 38. China Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Sickle Cell Disease Drug Sales Market Share by Country (2020-2031)
Figure 49. Latin America Sickle Cell Disease Drug Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Sickle Cell Disease Drug Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Sickle Cell Disease Drug Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Sickle Cell Disease Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Sickle Cell Disease Drug by Type (2020-2031)
Figure 59. Global Revenue Market Share of Sickle Cell Disease Drug by Type (2020-2031)
Figure 60. Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Sickle Cell Disease Drug by Application (2020-2031)
Figure 62. Global Revenue Market Share of Sickle Cell Disease Drug by Application (2020-2031)
Figure 63. Global Sickle Cell Disease Drug Price (USD/Pcs) by Application (2020-2031)
Figure 64. Sickle Cell Disease Drug Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
